Abstract | BACKGROUND: METHODS: RESULTS: A total of 167 patients were included. After 2 to 3 chemotherapy cycles, either surgery (38 patients) or radiation (104 patients) was conducted. Those who received surgery exhibited better survival than those who received radiation [median survival: not reached vs 33.6 months (95% CI: 22.6-44.7), p = .006]. The 5-year and 10-year survival rates of surgery group were 63.2% and 59.8%. CONCLUSION:
|
Authors | Yo-Han Cho, Se Hoon Lee, Dong-Wan Kim, Hong-Gyun Wu, J Hun Hah, Chae-Seo Rhee, Myung-Whun Sung, Kwang Hyun Kim, Dae Soeg Heo |
Journal | Head & neck
(Head Neck)
Vol. 30
Issue 3
Pg. 346-50
(Mar 2008)
ISSN: 1043-3074 [Print] United States |
PMID | 17972310
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | (c) 2007 Wiley Periodicals, Inc. Head Neck, 2008. |
Chemical References |
- Bleomycin
- Mitomycin
- Vincristine
- Etoposide
- Carboplatin
- Cisplatin
- Fluorouracil
|
Topics |
- Adolescent
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols
(administration & dosage)
- Bleomycin
(administration & dosage)
- Carboplatin
(administration & dosage)
- Carcinoma
(mortality, pathology, therapy)
- Cisplatin
(administration & dosage)
- Etoposide
(administration & dosage)
- Female
- Fluorouracil
(administration & dosage)
- Head and Neck Neoplasms
(mortality, pathology, therapy)
- Humans
- Male
- Middle Aged
- Mitomycin
(administration & dosage)
- Neoadjuvant Therapy
- Prognosis
- Radiotherapy, Adjuvant
- Survival Analysis
- Vincristine
(administration & dosage)
|